GlassScriptPhysician profile
Cory S Sejo
NPI 1790314086
$771.38
in general payments reported to CMS, 2019-2025
8 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $190 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $627 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $627.07 |
| Education | $144.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $358.01 | 2024-2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer |
| Endotronix, INC. | $140.50 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Abiomed | $122.86 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.17 | 2024-2025 | Lifevest |
| Edwards Lifesciences Corporation | $31.58 | 2024 | Pascal |
| Boston Scientific Corporation | $22.01 | 2025 | General - Therapies |
| Astrazeneca Pharmaceuticals LP | $19.90 | 2025 | Wainua |
| Teleflex LLC | $15.35 | 2025 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Sejo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.